The Aikenhead Centre for Medical Discovery business case was presented to the Victorian Government on the 31st October 2012.
A new way of terminating epileptic seizures with electrical simulation is on the cusp of human trials.
Seizures are detected and and a small stimulus is applied directly to the brain to interrupt this activity.
Approximately one per cent of the world’s population suffers from epilepsy and of these, 30-40 per cent have uncontrolled seizures despite medications. The majority of these medically refractory patients are unsuitable for surgery, the end result being a large, unmet need for alternative therapies.
People who are unable to control their seizures experience a drop in quality of life, often self-limiting their activities and social interactions, and there is an enormous financial cost of ongoing medical treatments and hospitalisations.
The ACMD research has the potential to provide seizure freedom and quality of life to millions of patients worldwide.